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1. Introduction
Tuberculosis (TB) is one of the infections with major impact worldwide and it is produced by
members of the Mycobacterium tuberculosis complex, this bacteria mainly affects the lungs. The
TB is considered the second cause of death for an infectious disease after of the Human
Immunodeficiency Virus(HIV)in the world [1]. It is one of the oldest diseases and has accom‐
panied mankind during its evolution. Evidence of the etiologic agent for the disease was found
in skeletons 4000 years old in Europe and the Middle East [2].According to the Global
Tuberculosis Report 2013 of the World Health Organization, in the 2012, an estimated 8.6
million new cases of diseased and 1.3 million deaths from this cause occurred. This data shows
that despite the many efforts of government organizations to control the disease, it remains an
important public health public worldwide.
In the last years the biology molecular methodologies have led many advances which allow
the analyses of genetic material of different microorganisms such as M. tuberculosis, with the
analysis of the Insertion element IS6110, the polymorphism within the direct repeat (DR) locus
and analysis using mycobacterial interspersed repetitive units, this methodologies allow the
molecular typing of the mycobacteria and the knowledge of the different lineages of M.
tuberculosis, contributing to the development of the molecular epidemiology and the control
politics of the disease in the different cities and countries.
2. General aspects of disease and etiologic agent
2.1. Epidemiology
TB is a global disease. In 2012, the World Health Organization(WHO) estimated in its annual
report about 8.6 million new cases of the disease (100,000 less than in 2011) which represents
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an incidence rate of 122 cases per 100,000 inhabitants in average worldwide: 5.7 million cases
were diagnosed as new cases, and it is estimated that 1.1 million of the total cases showed co-
infection infection with HIV; and 450,000 cases of multi-drug-resistant tuberculosis (MDR-TB),
being South East Asia, Africa, and the Pacific region the most affected areas. Additionally, an
estimate of 1.3 million deaths were caused by the disease, and despite of noticing a reduction
in the mortality rate, the increase of deaths in populations such as children and women is
remarkable.
On the other hand, approximately 2.9 million cases were lost, that is to say, they were not
diagnosed or they were not notified to the national tuberculosis programmes. Regarding
treatment, 56 million people were successfully treated from 1995 to 2012, saving 22 million
lives among the countries which adopted the Directly Observed Treatment, Short-course
(DOTS) strategy, proposed by the WHO.
According to the WHO report, the Americas and the Western Pacific regions are the only ones,
out of the six regions, which have achieved goals with regards to the decrease of mortality,
prevalence, and incidence by the year 2015.Prevalence of the disease was approximately 31 –
41 cases and incidence was 27 – 31 cases per 100,000 inhabitants in the Americas. Out of the
280,000 incident cases, about 31,000 showed co-infection with HIV; however only 219,349 cases
were reported. Mortality of the disease reached a rate of 1.9 deaths per 100,000 inhabitants,
that is to say 20,000 deaths among people suffering the disease.
In Colombia, 11990 confirmed cases of tuberculosis in all of its forms were confirmed for the
same period. Out of these, 10956 corresponded to new cases for an incidence of 23.5 cases per
100,000 inhabitants. According to the clinical presentation of the disease, 80.4% of cases were
pulmonary tuberculosis and 19.6% were extra pulmonary TB [3].
The departments with the largest number of cases in Colombia correspond to Antioquia,
Cundinamarca concentrating its high number of cases in the city of Bogota, Valle del Cauca,
Atlántico, Risaralda, and Santander.
2.2. Clinical forms
2.2.1. Pulmonary tuberculosis
It is the most common type since it is the manner in which the disease can be spread to other
persons. The disease is directly transmitted from person to person; when a diseased person
coughs, sneezes, or spits, bacilli are expelled to the air and they will be inhaled by people
around the patient [4].
It is estimated that one third of the world population has latent TB; that is to say, they are
infected by the bacillus but they have not gotten sick, nor they can spread the infection. People
infected with the tuberculosis bacillus have a 10% risk of getting TB throughout their lives.
However, this risk is higher for people who have a deficiency or compromise of their immune
system, as in cases of infection with the human immunodeficiency virus (HIV), malnutrition,
diabetes, or tobacco users [5].
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When the disease appears, the symptoms (coughing, fever, night sweats, and weight loss,
among others) may be mild for several months. As a result, patients delay seeking medical
attention and they transmit the bacteria to other people. During one year, a tuberculosis
diseased may infect approximately 10 to 15 people by close contact. Up to two thirds of
tuberculosis patients die if they do not receive appropriate treatment [6].
2.2.2. Extra pulmonary tuberculosis
Even though it represents only a small proportion of TB cases, approximately 10 – 15%, patients
develop the most severe forms of the disease. Since the disease may affect any organ, the
diagnosis is often more difficult and delayed [7]. Populations most affected by extra pulmonary
TB are children and persons with immunosuppression, such as those who have leukemia,
diabetes and living with HIV.
In accordance with the WHO criteria, the forms of extra pulmonary TB are classified into severe
and less severe. Meningitis, milliary, pericarditis, peritonitis, extensive or bilateral pleural,
intestinal, spinal, genital urinary are considered to be severe forms. TB of lymph nodes,
unilateral pleural, bones (except for the spine), and skin are considered to be the less severe [8].
2.3. Etiologic agent
The Mycobacterium genus is taxonomically located in the Mycobacteriacea family (table 1) and
comprises 150 species [9], among which there are species of the M. tuberculosis complex, made
up of M. tuberculosis, M. bovis, M bovis BCG, M. africanum, M microtti, M caprae, M. pinipedii, M.
canetti, M. mungi, M. orygis [10].
Kingdom Bacteria
Phylum Actinobacteria
Class Actinobacteria
Subclass Actinobacteridae
Order Actinomycetales
Suborder Corynebacterineae
Family Mycobacteriaceae
Genus Mycobacterium
Table 1. Taxonomic classification
2.3.1. Microscopic characteristics
The dimensions of the bacillus are approximately 1-10 µm long (usually 3-5 µm) and 0.2 –
0.6µm wide (Figure 1) [11]. It has a complex cellular envelope composed of a cellular membrane
and cellular wall; the latter provides mechanical support for the bacteria and gives its charac‐
teristic in acid-fast staining due to the large content of lipids [12]. The morphologic feature of
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presence of cord in the Zielh Neelsen staining is presumptive of mycobacteria of the M.
tuberculosis complex; formation of the cord is attributed to the trehalose glycolipid 6, 6-
dimycolate or cord factor composed of mycolic acids molecules [13].
Figure 1. Acid-fast bacilli in a bacilloscopy.
2.3.2. Morphologic characteristics in culture
M. tuberculosis is characterized by having slow growth in synthetic media since its generation
time ranges from 18 to 24 hours. Low growth rate is associated to the wall permeability which
limits the entry of nutrients [14] and additionally, it has been observed that one or two operons
rm are found in the mycobacteria managed by the P1 and P2 promoters. The rmA operon
located in the murA gene is found in all of the species, including M. tuberculosis and M.
leprae. Nevertheless, in some species such as the fast-growth ones, an additional rmB operon
is found, located in the tyrS gene [15, 16]
Synthetic media use for the isolation of M. tuberculosis contain nutrients such as glycerol,
carbon source, asparagine, and ammonia ions as source of nitrogen and micronutrients besides
albumin incorporated in the culture media with the aggregate of hen eggs or bovine seroal‐
bumin. Colonies characteristic of M. tuberculosis developed in a solid medium based on eggs
are often rough, without pigment, and dry (Figure 2) [17]
Figure 2. M. tuberculosis culture
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3. Genome of Mycobacterium tuberculosis
With the complete genome sequencing of M. tuberculosis, H37Rv strain, more genetic infor‐
mation of the bacterium was generated. In total, a sequence of 4,411,539 pairs of bases which
contain about 4000 genes and a high content of guanine + cytosine (G+C) of 65.6%. The point
for the beginning of numbering was the initiation codon for the dnaA gene, a marker for the
origin of replication oriC. The G+C content is relatively constant and several regions showing
larger content of G+C were detected, corresponding to sequences that belong to a large family
of genes which include the polymorphic GC-rich repetitive sequence (PGRS) [18].
Genome is rich in repetitive DNA, particularly in insertion sequences and in new multigene
families; an example of these is the presence and distribution of insertion sequences (IS). IS6110,
a sequence of the IS3 family, is of particular interest. It is widely used for typing of strains and
molecular epidemiology due to its variation in the insertion site and the number of copies [19].
In the H37Rv M. tuberculosis genome, sixteen copies of IS6110 were identified; some sites of
these copies were grouped in sites with the insertion name of hot spots[20].
Recently another repetitive region highly preserved within the chromosome of M. tuberculo‐
sis was described: the DR locus [21] [22], which is a member of the Clustered Regularly
Interspersed Palindromic Repeats – CRISP sequences [23]. After the discovery of the DR region,
the variable number of tandem repetitions (VNTR) was found [24], subsequently, the myco‐
bacterial intergenic repetition units (MIRU) were identified [25] that are also listed as VNTR
multiple locus analysis. Multilocus sequences typing (MLST) was introduced as an alternative
method [26]; and recently, the single nucleotide polymorphism (SNP) was described [27]
followed by large sequence polymorphism (LSP). The latter is carried out either by micro
arrangements or polymerase chain reaction (PCR) in real time [28]
4. Molecular markers of M. tuberculosis genotyping
4.1. IS6110
Insertion element found within species of the M. tuberculosis complex, and was shown to be
related to the IS3 family of insertion sequences which were discovered in members of the family
Enterobacteriaceae [29].
IS6110 is 1,361 bp long and contains 28-bp, imperfect inverted repeats at its extremities with
three mismatches and 3-bp direct repeats that probably result from repetition of the target
sequence [30] are present in different copy numbers and are integrated at various chromosomal
site [31]. The number of IS6110 copies present in the genome is species- and strain-dependent.
Most strains of M. tuberculosis carry between eight to 15 copies in different positions of the
genome although single copy strains are common. [32]The polymorphism of restriction
fragments generated by breaking the IS6110 fragment with the PvuII enzyme, has been used
as a method for genotyping of M. tuberculosis complex species
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4.2. IS1081, direct repeat and major polymorphic tandem repeat
It is a 1324-bp insertion sequence found in M. tuberculosis complex. It has a lower degree of
polymorphism than IS6110 because of its low transpositional activity [33, 34]
4.3. Polymorphic GC-rich repetitive sequence
It has numerous copies [35- 37] and consists of many tandem repeats of a 96 bp GC rich
consensus sequence. PGRS elements are present in 26 sites of M. tuberculosis chromosomes [38]
and have been detected in mycobacteria not belonging to the M. tuberculosis complex [39].
4.4. DR locus
It contains multiple repeated DR regions of 36 pb, interspersed with non-repetitive spacer
sequences of 34 to 41 pb which constitute DVR (Figure 3); the size of the DR locus varies from
6 DVR (06 kb) to 56 DVR (6 KB), and both the DR region and the spacers have shown little
variation in the order of presentation among strains.
The DR region has been identified as an integration hot-spot of the IS6110 insertion element [40].
Figure 3. DR locus
Deletion of one or more DVR [41] and duplication of DVR are the mechanisms which generate
the variation among different strains. These deletions and duplications are likely to be
mediated by the homologous recombination among neighboring or distant DRs, or by Splicing
processes during DNA replication [42]. Nevertheless, the process in which the deletion of a
DR occurs due to transposition of the IS6110 has also been described [43]. All of these changes
generated in the DR locus are the foundation for the development of the Spoligotyping
methodology [44].
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4.5. VNTR
DNA segments containing “tandem repeated” sequences in which the number of copies of the
repeated sequence varies among strains. Variable Number Tandem Repeat (VNTR) sequences
have emerged as valuable markers for genotyping. MIRUs are a class oftandem repeated
sequences. There are a total of 41 MIRU loci[45].
5. Genotyping methodologies
The following are the genotyping methodologies based on repetitive regions of the M.
tuberculosis chromosome mostly used worldwide:
• IS6110-based restriction fragment length polymorphism (RFLP) analysis.
• Spoligotyping.
• Mycobacterial interspersed repetitive units (MIRU) analysis
5.1. IS6110-RFLP methodology
Identification of IS6110 was a great break through for epidemiology of tuberculosis [46]. IS6110
is an insertion sequence made up by 1361 bp, capable of making copies of themselves and then
inserting the copies in a genome locus in a process known as transposition [47]. IS6110-based
restriction fragment length polymorphism analysis has been considered the golden standard
method for M. tuberculosis genotyping [48-49]. Strains of M. tuberculosis differ in the number
of IS6110 copies and their distribution is highly variable in the genome [50].
The first step in conducting RFLP is purification of DNA from a culture of M. tuberculosis; then
the Pvull restriction enzyme cuts the DNA on specific sequences in hundreds of different
fragments. The fragments are separated per size in an agarose gel and transferred to a
membrane. A probe is used in order to detect fragments containing IS6110; the picture is caught
on a film, and each IS6110 copy produces a band. RFLP patterns with seven or more bands
provide more specificity for discrimination of isolations, contrary to strains with patterns of
six or less bands in which there is lower discrimination. Usually, there are eight to 18 copies
per strains, but the number may vary from zero to 25 [51].
There is a small number of M. tuberculosis strain that do not contain the IS6110 sequence, so a
print without bands will be obtained in the analysis, or those which contain a low number of
copies will show less polymorphism than the ones containing a large number of copies. The
main disadvantages of this methodology is the complexity of the procedure which has a length
of approximately five days, and the amount of DNA necessary for the digestion with restriction
enzymes; this requires obtaining cultures with sufficient growth in order to perform DNA
extraction unlike PCR based methods such as MIRU and spoligotyping [52].
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5.2. Spoligotyping
It is a PCR-based method for detection and typing of the M. tuberculosis complex using a single
chromosome locus with high polymorphism, the direct repeated region DR. It consists on a
sequence of 36 pb which are separated by 43 non-repeated spacers, each of which contains 36
to 41 pairs of bases [53].
The amplification of the DR locus is carried out by means of PCR, using primers, one of which
is marked with biotin. The PCR products are hybridized perpendicularly to the membrane
that contains 43 oligonucleotides of known sequence. The membrane is incubated with
streptavidine-peroxydase conjugate which links to biotin of the PCR products. The detection
of hybridization signals is made by means of a chemiluminiscence system (ECL). When DR
regions of several strains are compared, the order of the spacers is almost the same in all of the
strains, but deletions of the spacers may be found which generate the differences among each
one of the strains [54].
In order to compare the patterns obtained with the results published, it is necessary to make
the conversion of the obtained bands pattern. Each one of the 43 spacers produces either a dark
box (indicating the presence of the spacer) or a clear box (indicating the absence of the spacer),
and a binary numeric code 1 -0 is assigned respectively.
To simplify this numbering, the 43-digit binary code is converted to a 15-digit octal code (i.e.
digits 0 to 7). Each 3-digit binary set is converted to its octal equivalent, and ultimately the
remaining digit shall be either 1 or 0. The translation of the binary numbers to octal numbers
is as follows: 000 = 0; 001 = 1; 010 = 2; 011 = 3; 100 = 4; 001 = 5; 110 = 6; 111 = 7. Each octal
designation is unique, thus representing a specific brands pattern [55]. Finally, this code is
entered in the SITVIT WEB international database which presents information on the diverse
lineages and its world distribution. It contains information about the genetic diversity of the
M. tuberculosis complex based on 62,582 clinical isolates from 153 countries [56].
Spoligotyping offers great advantages such as its usefulness in genotyping strains of M.
tuberculosis that contain little IS6110 sequences [57]; the use of the methodology directly on
clinical samples [58] which would allow simultaneous diagnosis and typing of M. tuberculosis,
M. bovis, and differentiation of species comprising the M. tuberculosis complex. Studies
conducted with clinical samples showed unique hybridization pattern, whereas strains of an
outbreak shared the same pattern. Patterns obtained from direct examination of the clinical
samples were identical to the ones obtained by means of using DNA from cultures of these
samples [59].The use of a second generation spoligotyping membrane was proposed with the
aim of increasing the test´s power of discrimination using 51 oligonucleotides of spacers [60].
By using spoligotyping, species and subspecies comprising the M. tuberculosis complex can be
classified based on the patterns obtained on hybridization, and at the same time the diverse
lineages of the M. tuberculosis species [61].
5.3. MIRU-VNTR methodology
Mycobacterial interspersed repetitive units are loci in the genome of M. tuberculosis containing
a number of variable tandem repetitions [62]. The length of MIRU is in the range of 50 – 100
pb and belong to the category of VNTR “mini satellites” [63]. Forty-one loci of this type have
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been identified in M. tuberculosis, among them, 12 loci have shown that they vary in the number
of tandem repetitions and most of them among the repeating units.
It is a PCR-based method that uses these 12 different interspersed units for genotyping. The
estimation to determine the number of repetitions is based on the size of the amplicon. The
results are reported as 12 numbers, each one corresponding to the number of repetitions. The
power of discrimination of the 12 MIRU-VNTR regions is much greater than the one of
spoligotyping and close to IS6110 RFLP for typing of M. tuberculosis strains. Recently a system
was proposed which includes typing of 24-loci MIRU-VNTR combining multiplex PCR
analysis or a DNA analyzer based on fluorescence with the computer automation of genotyp‐
ing was proposed [64].
6. Species and lineages of M. tuberculosis
6.1. M. tuberculosis
It was the first member of the complex to be described by Doctor Robert Koch in 1882. It is the
species most frequently involved in the development of pulmonary TB in humans [65].M.
tuberculosisis by far the most important pathogen of the complex in terms of the number of
infected hosts and its public health implications.
6.2. M. bovis
It causes TB in a wide range of wild and domestic animals. M. bovis is naturally resistant to
pyrazinamide, a first-line anti TB drugs[66]. Its epidemiologic importance lies in the zoonotic
transmission of M. bovis to humans due to contact with infected animals, or to consumption
of products from these animals.
6.3. M. africanum
It is the species that causes more TB in humans in Western Africa [67]. There are two large
variants of M. africanum: the African Variation I, isolated in the east of Africa, and variant II,
to the west [68]. Besides, M. africanum type I has been recently subdivided into M. africanum
type I, eastern African I (MAF1), prevalent around the Gulf of Guinea; and M. africanum type
I, eastern African 2 (MAF2), prevalent in southeast Africa. M. africanum type II has been
reclassified into M. tuberculosis and indicated as the “Uganda” genotype [46].
6.4. M. bovis BCG or Bacillus Calmette-Guerin (BCG)
It is the vaccine’s strain, and it is a live attenuated variant of M. bovis. Its spoligotype is
characterized by the absence of spacers 3, 10, 17, 22, and 39 to 43 [47].The efficacy of this vaccine
varies in different populations, with a consistently low efficacy in many tropical regions of the
world [48], [49]. High efficacy when BCG is used to vaccinate newborns. Neonatal vaccination
with BCG imparts protection against the childhood manifestations of TB (in particular,
meningitis) [50], [51].
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6.5. M. microti
It causes the disease in voles,wood mice and shrews. Its isolation is rare in human clinical
samples, but recently, isolations from humans have been characterized. The spoligotypes
analysis in isolates reveals the single presence of spacers 37 and 38 [53].
6.6. M. canetti
It was added to the list of M. tuberculosis complex in 1997. It isolated in 1993 from a 2-year-old
Somali child with lymphadenitis, this isolate exhibited an unusually smooth and glossy colony
morphology. To this date there have been few reports of TB cases due to this subspecies, and
it is thought that animals are natural hosts of the bacterium [52].
6.7. M. caprae
This subspecies has been isolated mainly from goats in Spain [44], but it has also been found
in boars, pigs, and in some cases of persons related to goat breeding [54]. The genetic footprint
obtained by spoligotyping is characterized by the absence of spacers 1, 3 to 16, 10 to 33, and
39 to 43 [54].
6.8. M. pinnipedii
It was originally isolated from TB cases in pinnipeds such as sea lions and seals. Recently, cases
have been described in terrestrial animals such as the Brazilian tapir. Its spoligotype has only
the spacers 25 to 38 [55].
6.9. M. mungi
Identified in 2010 as a pathogen of the M. tuberculosis complex as TB causal agent in banded
mongooses that live close to humans in the district of Chobe, Botswana, because these animals
live in human-made structures and scavenge human waste, including feces.TB has been
identified in only humans and mongooses. Strain assessment of human TB has not been
conducted; the full host spectrum and transmission dynamics of this pathogen, currently
unknown [56].
The spoligotype pattern of M. mungi isolates is characterized by absence of spacers 3, 7, 9, 12
to 36, and 39. It was determined that this pattern is preserved in the described isolates, but it
is not included yet in international databases [56].
6.10. M. orygis
Species described in 2012 by Van Ingen and collaborators. It has been isolated from members
of the Bovidae family such as oryx, gazelles, antelopes, cows, rhesus monkeys and waterbucks,
although their exact host range remains unsettled, however cases have been described in
humans [57]. Its spoligotype pattern is characterized by the absence of spacers 4-9, 14-24. 35,
36, and 39.The most common spoligotype (ST587) is present in the SITVIT WEB database and
labeled M. africanum [58].
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6.11. M. tuberculosis lineages (Fig. 4)
The lineages of M. tuberculosis are distributive a worldwide.
6.12. Haarlem (H)
Characterized by a pattern with absence of spacer 31 and the presence of at least one spacer
between 1 and 30. It is highly prevalent in Northern Europe, while it is less extended in the
Caribbean and Central Africa, where it is thought to be introduced by the European coloni‐
zation [59].
6.13. Latin America and Mediterranean (LAM)
Characterized by the absence of spacers 21 to 24, 33 to 36, and the presence of at least one spacer
between 1 and 30. It is frequent in Mediterranean and Latin American countries. Some
genotypes have shown strong geographic associations, for instance LAM10-Cameroon or
LAM7-Turkey which were initially catalogued as LAM although there has not been phyloge‐
netic association with other spoligotypes [60, 61].
6.14. T Lineage
Comprised by modern strains of TB. This lineage is characterized “by default” and it includes
strains which are difficult to classify into other groups [11] It has absence of spacers 33 to 36
and presence of at least one spacer between 1 to 30 besides the presence of the spacers 9 or 10,
and 31; there is also presence of one spacer between 21 to 24 [62].
6.15. X lineage
Its pattern has absence of spacers 18 and 33 to 36. It was identified in Anglo-Saxon cities, and
it is highly prevalent in South Africa, less in Latin America. However, there is high presence
of this genotype in Mexico, which can be explained by its closeness to the United States. The
X lineage was the first group identified in Guadeloupe [63] and the French Polynesia [64].
6.16. East African-Indian (EAI)
Absence of spacers 29 to 32 and 34; and presence of at least one spacer between 1 and 30. It is
frequent in South East Asia, India, and Western Africa [62].
6.17. Central Asian (CAS)
Absence of spacers 4 to 27, and 23 to 34. It is highly prevalent in sub-Saharan countries and
Pakistan. This linage has also proved to be endemic in Sudan, sub-Saharan countries, and
Pakistan. This spoligotype has numerous variants and subgroups such as CAS1-Kili (Kili‐
manjaro), CAS-Dar (Dar-es-Salaam), and CAS-Delhi [62].
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6.18. Beijing
This genotype has absence of spacers 1 to 33 and presence of spacers 34 to 43; in terms of public
health it continues to be a serious problem for TB control due to its high virulence and
association with multi-drug resistance [11].
6.19. MANU
It may be the ancestral clone of the strains in genetic group 1. It was subdivided into Manu 1
(absence of spacer 34), Manu 2 (absence of spacers 33-34), and Manu 3 (absence of spacers 34
to 36). It is a new family from India [62].
Figure 4. World distribution of lineages M. tuberculosis (Modified of Demay,2012)
7. Molecular epidemiology support in controlling tuberculosis
Molecular epidemiology has become in recent years an essential tool in the study of cases of
tuberculosis, together with classical epidemiology, thus making the analysis of situations such
as:
• Early detection and rapid control of outbreaks.
• Set transmission cases restricted communities
• Establish the geographic origin of the strains
• Monitoring of cross-contamination in the laboratories of TB
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• Detection of genotypes associated with drug resistance
• Differentiation of cases of relapse and reinfection
In the analysis of data obtained by molecular epidemiology is essential to know definitions
created from the development of molecular epidemiology, as they are
Cluster: A genotyping cluster is two or more M. tuberculosis isolates that share matching
genotypes or the same DNA fingerprinting. An epidemiologic cluster is two or more persons
with TB who share known epidemiologic links [38].
Matching genotypes: two or more M. tuberculosis isolates that share the same genotype.
Nonmatching genotype: an isolate that has a unique genotype (i.e., a genotype pattern that
does not match the pattern of any other isolate in a TB program’s database) [38].
7.1. Early detection of outbreaks
Analysis of clinical isolates of certain areas can help determine if isolates share the same
genotype, and they form a cluster. But additionally be analyzed factors such as place of
residence, work and time spent on them [38].
Genotypic guide Atlanta CDC studies raises three criteria for an outbreak [38].
1. An increase in the expected number of TB cases.
2. Transmission continues despite adequate control efforts by the TB program.
3. The contact investigation has grown to a size that requires additional outside help.
7.2. Transmission between cases of restricted communities
In conducting the study epidemiologically linked contacts and TB patients can be established
[38]:
• Epidemiologic links between two TB cases that were identified during contact investigations
and later confirmed by subsequent cluster investigations.
• New epidemiologic links that were identified during cluster investigations but not discov‐
ered during previous contact investigations.
7.3. Establishment of the geographical origin of the isolates
The analysis of several clinical isolates obtained worldwide, has established partnerships
lineages with specific geographical areas, and in the case of LAM lineage or Latin American
and Mediterranean, which as its name suggests occurs at high frequency in these geographic
areas. The EIA or East African Indian [41].
7.4. Detecting genotypes associated drug resistance
The main genotype associated with drug resistance is the Beijing genotype, these strains exhibit
high virulence and ease of propagation, but additionally the majority of clinical isolates
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belonging to this lineage with mutations that confer drug resistance, so its eradication much
more difficult in the population, was first identified in China in 1995 [65], but has quickly
spread to other countries, and has been responsible for outbreaks of MDR-TB [66, 67]:
7.5. Differentiation of relapses and reinfections
Initially, we must take into account in terms of TB programs, it only considers the situation of
relapse which is defined as a patient previously treated for TB who has been declared cured
or completed treatment and is newly diagnosed with bacteriologically positive tuberculosis.
But the genotypic analysis classifies this situation relapse and reinfection, which are defined
as, a case of relapsed TB represents a worsening of an infection after a period of improvement
and is caused by the same strain of M. tuberculosis. TB that represents a reinfection is caused
by a second infection with a strain that is different from the strain that caused the initial
infection [38].
7.6. Cross contamination in the laboratories of TB
With the genotypic analysis of clinical isolates processed in a laboratory during the same time
period can be set if cross-contamination occurred between crops.
Genotyping can help identify instances of incorrect TB diagnoses that are based on false
positive cultures. Incorrect diagnoses can result from laboratory cross-contamination of
cultures during batch processing, pipetting, transfer of bacilli from a broth-culture system,
work in a faulty exhaust hood, and species-identification procedures, mislabeling of patient
specimens, clinical equipment contaminated [38].
The identification of cross-contamination in a laboratory setting allows control measures to
prevent patients are misdiagnosed.
7.7. Incorporating genotyping methodologies in TB diagnostic laboratories
Since the development of the genotyping methodologies, especially those that are based on
nucleic acid amplification, it has been observed their advantage for use with isolated genetic
material directly from clinical samples. Examples of these methodologies is spoligotyping,
described by Kameberck, which allows simultaneous detection and typing of M. tuberculosis.
Rapid identification and genotyping of M. tuberculosis families through the methodology
implemented in multibacillary cases of TB, causing the rapid spread of the disease in com‐
munity, reduce the time between suspicion of disease and treatment. Additionally, the
application of the methodology of Spoligotyping in paucibacillary cases allows for quick
diagnosis in cases of extrapulmonary tuberculosis, and rapid identification of M. tuberculosis
complex species involved in the infection, supporting the clinician in addressing treatment.
8. Conclusion
The methods most commonly used in developing countries via bacteriological diagnoses were
smear and culture show the presence of the causative agent of the disease. Currently being
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implemented new, more sensitive diagnostic technologies based on the detection of deoxyri‐
bonucleic acid (DNA) mycobacterial [68] and with which results are obtained in less time.
Some of these methods provide the additional advantage of performing genotyping processes
allowing the identification of family or families of M. tuberculosis present in the region, some
of these methods are the analysis of the insertion sequence IS6110, polymorphism of the spacer
sequences of Direct repeat region DR and analysis of the intergenic repeat units mycobacterial
MIRU, and thus support the strategies of disease control with the detection of cases, relapse,
and reinfection of new strain circulation, thus contributing to the development of molecular
epidemiology.
9. Application exercise
9.1. Exercise 1: analyses of cases
Case 1
Patient presented an episode of TB in 2010, he completed his treatment but with some
disruption, then in 2013, he presents a new case of TB. The following are spoligotypes patterns
identified for Spoligotyping in each of the isolated (table 2).
                            
 
 
 
 
2010   LAM9 
2013   LAM9 
  
 
 
 
 
 
Table 2. Spoligotypes case 1
Case 2
Patient presented an episode of TB in 2012, he completed his treatment in June of this year. In
October 10th 2013, the patient was diagnosed with TB. The analyses for spoligotyping of the
strains showed the following patterns (table 3).
 
   
2012   T1 
2013   LAM2 
  
 
 
 
 
 
 
Table 3. Spoligotypes case 2
Questions
1. Define the situation of each case, justified your response
2. Which other diagnosis methodologies you can use for confirmation the case.
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9.2. Exercise 2
Complete the gaps on the table 4
Number Binary code Octal code SIT Lineage
001 1101111111110111111100001111111100001111111
002 1111111111111111111111111111111100001111111
003 1111111111111111111100001111111100001111111
004 273
005 1111111111111111111111111000000100001110111 777777774020731 62
006 91
007 1111111111111111111100001111111100001111111
008 1111111111111111111111111000000100001110111
009 777777777720771
010 0000000000000000000000000000000000111111111 000000000003771 1
011 1111111111111111111111111111110100001111111
012 447
013 1111111111111111111111101111111100001111111
014 1111111111111111111111111111111100001111111
015 1101111111110111111100001111111100001111111
016 1110000111111111111111000000000000111111111
017 1001111111111111111111111111000010110001111 11
018 777777607760771
019 1111111111111101111111111111111100001111111
020 1111111111111111111100001111111100001111111
021 373
022 42
023 64
024 777777477760771
025 1111111100111111111111110000000000001110111
026 0000111111111111111000001111011100001110111
027 1111111111111111111101111111111100001110111
028 1111111111111111111100001111111100001111111
029 33
030 53
Table 4. Exercise 2
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